
Vatilen®
Palbociclib
Therapeutic action
Cyclin-dependent kinase inhibitor
Indications
HR-positive, HER2-negative advanced or metastatic breast cancer
Presentation
21 Hard capsules
Cyclin-dependent kinase inhibitor
HR-positive, HER2-negative advanced or metastatic breast cancer